Douglas S Ingram - Net Worth and Insider Trading
Douglas S Ingram Net Worth
The estimated net worth of Douglas S Ingram is at least $52 Million dollars as of 2024-04-17. Douglas S Ingram is the President & CEO of Sarepta Therapeutics Inc and owns about 390,307 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $46 Million. Douglas S Ingram is the President of Allergan PLC and owns about 30,101 shares of Allergan PLC (AGN) stock worth over $6 Million. Douglas S Ingram is also the Director of Relay Therapeutics Inc and owns about 25,000 shares of Relay Therapeutics Inc (RLAY) stock worth over $155,250. Besides these, Douglas S Ingram also holds Endo International PLC (ENDPQ) . Details can be seen in Douglas S Ingram's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas S Ingram has not made any transactions after 2023-11-03 and currently still holds the listed stock(s).
Transaction Summary of Douglas S Ingram
Douglas S Ingram Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas S Ingram owns 5 companies in total, including Relay Therapeutics Inc () , Sarepta Therapeutics Inc () , and Skye Bioscience Inc () among others .
Click here to see the complete history of Douglas S Ingram’s form 4 insider trades.
Insider Ownership Summary of Douglas S Ingram
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Relay Therapeutics Inc | 2020-07-20 | director | |
Sarepta Therapeutics Inc | 2023-11-03 | director & President & CEO | |
Skye Bioscience Inc | 2015-06-01 | director & Vice Chairman | |
ECC Capital Corp | 2005-02-18 | director | |
Endo International PLC | 2016-05-05 | director |
Douglas S Ingram Latest Holdings Summary
Douglas S Ingram currently owns a total of 4 stocks. Among these stocks, Douglas S Ingram owns 390,307 shares of Sarepta Therapeutics Inc (SRPT) as of November 3, 2023, with a value of $46 Million and a weighting of 88.52%. Douglas S Ingram owns 30,101 shares of Allergan PLC (AGN) as of February 21, 2014, with a value of $6 Million and a weighting of 11.18%. Douglas S Ingram also owns 25,000 shares of Relay Therapeutics Inc (RLAY) as of July 20, 2020, with a value of $155,250 and a weighting of 0.3%. The other 1 stocks Endo International PLC (ENDPQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Douglas S Ingram
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SRPT | Sarepta Therapeutics Inc | 2023-11-03 | 390,307 | 117.89 | 46,013,292 |
AGN | Allergan PLC | 2014-02-21 | 30,101 | 193.02 | 5,810,095 |
RLAY | Relay Therapeutics Inc | 2020-07-20 | 25,000 | 6.21 | 155,250 |
ENDPQ | Endo International PLC | 2016-05-05 | 4,890 | 0.00 | 3 |
Holding Weightings of Douglas S Ingram
Douglas S Ingram Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas S Ingram has made a total of 3 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Sarepta Therapeutics Inc is the acquisition of 25,225 shares on November 3, 2023, which cost Douglas S Ingram around $2 Million.
According to the SEC Form 4 filings, Douglas S Ingram has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 1 shares on February 21, 2014, which brought Douglas S Ingram around $126.
According to the SEC Form 4 filings, Douglas S Ingram has made a total of 1 transactions in Relay Therapeutics Inc (RLAY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Relay Therapeutics Inc is the acquisition of 25,000 shares on July 20, 2020, which cost Douglas S Ingram around $500,000.
More details on Douglas S Ingram's insider transactions can be found in the Insider Trading History of Douglas S Ingram table.Insider Trading History of Douglas S Ingram
- 1
Douglas S Ingram Trading Performance
GuruFocus tracks the stock performance after each of Douglas S Ingram's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas S Ingram is 6.11%. GuruFocus also compares Douglas S Ingram's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas S Ingram within 3 months outperforms 5 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas S Ingram's insider trading performs compared to the benchmark.
Performance of Douglas S Ingram
Average Relative Return
50.97%
Outperforming Transactions
57%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | -0.69 | 6.11 | 22.25 | 50.97 | 14.28 | 4.11 |
Relative Return to S&P 500(%) | -3.1 | 3.5 | 15.08 | 40.83 | 3.94 | -9.58 |
Douglas S Ingram Ownership Network
Ownership Network List of Douglas S Ingram
Ownership Network Relation of Douglas S Ingram
Douglas S Ingram Owned Company Details
What does Relay Therapeutics Inc do?
Who are the key executives at Relay Therapeutics Inc?
Douglas S Ingram is the director of Relay Therapeutics Inc. Other key executives at Relay Therapeutics Inc include See remarks Peter Rahmer , Vice President & Finance Thomas Catinazzo , and See Remarks Donald A Bergstrom .
Relay Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Douglas S Ingram made no insider transaction in Relay Therapeutics Inc (). Other recent insider transactions involving Relay Therapeutics Inc () include a net sale of 19,517 shares made by Brian Adams , a net sale of 12,255 shares made by Thomas Catinazzo , and a net sale of 26,393 shares made by Donald A Bergstrom .
In summary, during the past 3 months, insiders sold 5,415 shares of Relay Therapeutics Inc () in total and bought 0 shares, with a net sale of 5,415 shares. During the past 18 months, 235,433 shares of Relay Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 235,433 shares.
Relay Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Relay Therapeutics Inc Insider Transactions
Douglas S Ingram Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas S Ingram. You might contact Douglas S Ingram via mailing address: 2525 Dupont Dr, Irvine Ca 92612.